Research database

SVF Research Library

Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 39 matching records.

Search the database

Evidence

Sort

39 results — page 1 of 2

Level DNarrative ReviewEurope PMC
Advancements in omics technologies: Molecular mechanisms of acute lung injury and acute respiratory distress syndrome (Review)
Narrative Review on Chronic Inflammation, published in Int J Mol Med (2025) — summary generated from the PubMed abstract.
2025
Int J Mol Med
10 citations
Level DAnimal StudyEurope PMC
Primed Mesenchymal Stem Cells by IFN-γ and IL-1β Ameliorate Acute Respiratory Distress Syndrome through Enhancing Homing Effect and Immunomodulation
Animal Study on Chronic Inflammation, Immune Modulation, published in Biomol Ther (Seoul) (2025) — summary generated from the PubMed abstract.
2025
Biomol Ther (Seoul)
3 citations
Level DNarrative ReviewEurope PMC
Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies
Narrative Review on Face & Skin, published in Signal Transduct Target Ther (2025) — summary generated from the PubMed abstract.
2025
Signal Transduct Target Ther
71 citations
Level BClinical TrialEurope PMC
Nebulization of Mesenchymal Stem Cells Secretome Attenuates Acute Respiratory Distress Syndrome Caused by SARS-CoV-2 Corona Virus: An Open-Label, Controlled Trial
Clinical Trial with a reported sample of 19 on Chronic Inflammation, Immune Modulation, published in Adv Biomed Res (2025) — summary generated from the PubMed abstract.
2025
Adv Biomed Res
n = 19
Level DLaboratory StudyEurope PMC
Native and Engineered Extracellular Vesicles for the Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome
Laboratory Study, published in Small Sci (2025) — summary generated from the PubMed abstract.
2025
Small Sci
Level CProspective StudyPubMed
Interleukin-27-adipose-derived mesenchymal stromal cell-based gene therapy attenuates inflammation in lipopolysaccharide-induced acute respiratory distress syndrome.
Prospective Study on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2025) — summary generated from the PubMed abstract.
2025
Stem Cell Res Ther
1 citations
Level DAnimal StudyPubMed
Outcomes of combined mitochondria and mesenchymal stem cells-derived exosome therapy in rat acute respiratory distress syndrome and sepsis.
Animal Study, published in World J Stem Cells (2024) — summary generated from the PubMed abstract.
2024
World J Stem Cells
1 citations
Level DNarrative ReviewEurope PMC
Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers
Narrative Review on Chronic Inflammation, Immune Modulation, published in Braz J Med Biol Res (2024) — summary generated from the PubMed abstract.
2024
Braz J Med Biol Res
3 citations
Level BClinical TrialPubMed
Evaluating the therapeutic potential of different sources of mesenchymal stem cells in acute respiratory distress syndrome.
Clinical Trial on Chronic Inflammation, Immune Modulation, published in Stem Cell Res Ther (2024) — summary generated from the PubMed abstract.
2024
Stem Cell Res Ther
Level AMeta-analysisEurope PMC
Efficacy and safety of several common drugs in the treatment of acute respiratory distress syndrome: A systematic review and network meta-analysis
Meta-analysis with a reported sample of 3492, published in Medicine (Baltimore) (2024) — summary generated from the PubMed abstract.
2024
Medicine (Baltimore)
n = 3492
Level BClinical TrialPubMed
Current status and prospects of basic research and clinical application of mesenchymal stem cells in acute respiratory distress syndrome.
Clinical Trial on Chronic Inflammation, Immune Modulation, published in World J Stem Cells (2023) — summary generated from the PubMed abstract.
2023
World J Stem Cells
Level BClinical TrialPubMed
Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome.
Clinical Trial on Immune Modulation, published in Respir Res (2023) — summary generated from the PubMed abstract.
2023
Respir Res
2 citations
Level BClinical TrialEurope PMC
Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic
Clinical Trial on Chronic Inflammation, published in Front Immunol (2023) — summary generated from the PubMed abstract.
2023
Front Immunol
14 citations
Level DAnimal StudyPubMed
[Effects and mechanism of annexin A1-overexpressing human adipose-derived mesenchymal stem cells in the treatment of mice with acute respiratory distress syndrome].
Animal Study on Chronic Inflammation, published in Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi (2023) — summary generated from the PubMed abstract.
2023
Zhonghua Shao Shang Yu Chuang Mian Xiu Fu Za Zhi
2 citations
Level BClinical TrialEurope PMC
Stem Cell-based therapies for COVID-19-related acute respiratory distress syndrome
Clinical Trial, published in J Cell Mol Med (2022) — summary generated from the PubMed abstract.
2022
J Cell Mol Med
1 citations
Level CProspective StudyEurope PMC
The downregulation of miR-129-5p relieves the inflammatory response in acute respiratory distress syndrome by regulating PPARγ-mediated autophagy
Prospective Study on Chronic Inflammation, published in Ann Transl Med (2022) — summary generated from the PubMed abstract.
2022
Ann Transl Med
10 citations
Level CProspective StudyPubMed
Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.
Prospective Study on Chronic Inflammation, published in Front Immunol (2022) — summary generated from the PubMed abstract.
2022
Front Immunol
Level DAnimal StudyPubMed
HGF-Modified Dental Pulp Stem Cells Mitigate the Inflammatory and Fibrotic Responses in Paraquat-Induced Acute Respiratory Distress Syndrome.
Animal Study on Chronic Inflammation, published in Stem Cells Int (2021) — summary generated from the PubMed abstract.
2021
Stem Cells Int
Level BClinical TrialEurope PMC
Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives
Clinical Trial, published in J Leukoc Biol (2021) — summary generated from the PubMed abstract.
2021
J Leukoc Biol
25 citations
Level BClinical TrialPubMed
Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.
Clinical Trial with a reported sample of 19, published in J Transl Med (2021) — summary generated from the PubMed abstract.
2021
J Transl Med
23 citations
n = 19
Level AMeta-analysisPubMed
Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.
Meta-analysis with a reported sample of 117 on Systemic / IV, published in Stem Cells Transl Med (2020) — summary generated from the PubMed abstract.
2020
Stem Cells Transl Med
n = 117
Level CProspective StudyPubMed
Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome.
Prospective Study on Chronic Inflammation, published in Semin Respir Crit Care Med (2020) — summary generated from the PubMed abstract.
2020
Semin Respir Crit Care Med
Level DNarrative ReviewEurope PMC
The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect
Narrative Review on Immune Modulation, published in Stem Cells Transl Med (2020) — summary generated from the PubMed abstract.
2020
Stem Cells Transl Med
38 citations
Level DNarrative ReviewEurope PMC
Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection
Narrative Review with a reported sample of 19 on Immune Modulation, published in World J Stem Cells (2020) — summary generated from the PubMed abstract.
2020
World J Stem Cells
22 citations
n = 19

In-depth reviewed studies (full Thai translation)

Evidence system

SVF Research Library

Advancements in omics technologies: Molecular mechanisms of acute lung injury and acute respiratory distress syndrome (Review)

Primed Mesenchymal Stem Cells by IFN-γ and IL-1β Ameliorate Acute Respiratory Distress Syndrome through Enhancing Homing Effect and Immunomodulation

Advances in acute respiratory distress syndrome: focusing on heterogeneity, pathophysiology, and therapeutic strategies

Nebulization of Mesenchymal Stem Cells Secretome Attenuates Acute Respiratory Distress Syndrome Caused by SARS-CoV-2 Corona Virus: An Open-Label, Controlled Trial

Native and Engineered Extracellular Vesicles for the Treatment of Acute Lung Injury and Acute Respiratory Distress Syndrome

Interleukin-27-adipose-derived mesenchymal stromal cell-based gene therapy attenuates inflammation in lipopolysaccharide-induced acute respiratory distress syndrome.

Outcomes of combined mitochondria and mesenchymal stem cells-derived exosome therapy in rat acute respiratory distress syndrome and sepsis.

Multipotent mesenchymal stromal/stem cell-based therapies for acute respiratory distress syndrome: current progress, challenges, and future frontiers

Evaluating the therapeutic potential of different sources of mesenchymal stem cells in acute respiratory distress syndrome.

Efficacy and safety of several common drugs in the treatment of acute respiratory distress syndrome: A systematic review and network meta-analysis

Current status and prospects of basic research and clinical application of mesenchymal stem cells in acute respiratory distress syndrome.

Integrin α10β1-selected mesenchymal stem cells reduced hypercoagulopathy in a porcine model of acute respiratory distress syndrome.

Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic

[Effects and mechanism of annexin A1-overexpressing human adipose-derived mesenchymal stem cells in the treatment of mice with acute respiratory distress syndrome].

Stem Cell-based therapies for COVID-19-related acute respiratory distress syndrome

The downregulation of miR-129-5p relieves the inflammatory response in acute respiratory distress syndrome by regulating PPARγ-mediated autophagy

Mesenchymal stromal cells as treatment for acute respiratory distress syndrome. Case Reports following hematopoietic cell transplantation and a review.

HGF-Modified Dental Pulp Stem Cells Mitigate the Inflammatory and Fibrotic Responses in Paraquat-Induced Acute Respiratory Distress Syndrome.

Effects of mesenchymal stromal cell-derived extracellular vesicles in acute respiratory distress syndrome (ARDS): Current understanding and future perspectives

Therapeutic mechanisms of mesenchymal stem cells in acute respiratory distress syndrome reveal potentials for Covid-19 treatment.

Cell-based therapy to reduce mortality from COVID-19: Systematic review and meta-analysis of human studies on acute respiratory distress syndrome.

Mesenchymal Stem/Stromal Cells Therapy for Sepsis and Acute Respiratory Distress Syndrome.

The rationale of using mesenchymal stem cells in patients with COVID-19-related acute respiratory distress syndrome: What to expect

Mesenchymal stromal cells as potential immunomodulatory players in severe acute respiratory distress syndrome induced by SARS-CoV-2 infection

In-depth reviewed studies (full Thai translation)

Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial

Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials

Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis